FDA Inspection 949174 — Ascent Pharmaceuticals Inc

Ascent Pharmaceuticals Inc — FEI 3009518416

The FDA completed an inspection of Ascent Pharmaceuticals Inc on November 9, 2015 in Central Islip, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 9, 2015
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Central Islip, NY (United States)